Comment déveloper un antidépresseur au mécanisme d’action innovant : l’exemple de l’agomélatine

Author: Mocaër Elisabeth   Delalleau Bruno   Boyer Pierre-Alain   de Bodinat Christian  

Publisher: Edp Sciences

E-ISSN: 1958-5381|21|10|888-894

ISSN: 0767-0974

Source: Médecine/sciences, Vol.21, Iss.10, 2010-11, pp. : 888-894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract